Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

Small-cell lung cancer (SCLC) has a poor prognosis and can be diagnosed with systemic metastases. Nevertheless, the molecular mechanisms underlying the development of SCLC are unclear, requiring further investigation. The current research aims to identify relevant biomarkers and available drugs to t...

Full description

Bibliographic Details
Main Authors: Li Yi, Zhou Xiwen, Lyu Zhi
Format: Article
Language:English
Published: De Gruyter 2023-10-01
Series:Open Medicine
Subjects:
Online Access:https://doi.org/10.1515/med-2023-0806